FDA Inspection
CorneaGen, Inc.CorneaGen, Inc. – FDA Inspection, Jun 17, 2013
Record Details
This FDA Inspection record concerns CorneaGen, Inc., with an inspection on June 17, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CorneaGen, Inc.
- Inspection Date
- June 17, 2013
- Product Type
- Biologics
View Company Profile
ID · 70266549-6fb8-4dad-a3eb-91b42632b947
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 836377
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of CorneaGen, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 10, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 29, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 27, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 15, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen, Inc.
- FDA Inspection 1282090 - 2025-09-10
- FDA Inspection 1176014 - 2022-07-29
- FDA Inspection 1047476 - 2018-02-27
- FDA Inspection 977565 - 2016-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.